2. Academic Validation
  3. The mucosae-associated epithelial chemokine (MEC/CCL28) modulates immunity in HIV infection

The mucosae-associated epithelial chemokine (MEC/CCL28) modulates immunity in HIV infection

  • PLoS One. 2007 Oct 3;2(10):e969. doi: 10.1371/journal.pone.0000969.
Eleonora Castelletti 1,  Sergio Lo Caputo,  Louise Kuhn,  Manuela Borelli,  Johanna Gajardo,  Moses Sinkala,  Daria Trabattoni,  Chipepo Kankasa,  Eleonora Lauri,  Alberto Clivio,  Luca Piacentini,  Dorothy H Bray,  Grace M Aldrovandi,  Donald M Thea,  Francisco Veas,  Manuela Nebuloni,  Francesco Mazzotta,  Mario Clerici
Affiliations

Affiliation

  • 1 Department of Preclinical Sciences, Laboratorio Interdisciplinare Technologie Avanzate Vialba, University of Milano, Milano, Italy.
PMID: 17912348 DOI: 10.1371/journal.pone.0000969
Abstract

Background: CCL28 (MEC) binds to CCR3 and CCR10 and recruits IgA-secreting plasma cells (IgA-ASC) in the mucosal lamina propria (MLP). Mucosal HIV-specific IgA are detected in HIV-infection and exposure. The CCL28 circuit was analyzed in HIV-infected and-exposed individuals and in HIV-unexposed controls; the effect of CCL28 administration on gastrointestinal MLP IgA-ASC was verified in a mouse model.

Methodology/findings: CCL28 was augmented in breast milk (BM) plasma and saliva of HIV-infected and -exposed individuals; CCR3+ and CCR10+ B lymphocytes were increased in these same individuals. Additionally: 1) CCL28 concentration in BM was associated with longer survival in HIV vertically-infected children; and 2) gastro-intestinal mucosal IgA-ASC were significantly increased in VSV-immunized mice receiving CCL28.

Conclusions: CCL28 mediates mucosal immunity in HIV exposure and Infection. CCL28-including constructs should be considered in mucosal vaccines to prevent HIV Infection of the gastro-intestinal MLP via modulation of IgA-ASC.

Figures
Products